Our focus was on four core cancer-related genes of the ERCC family (ERCC2, ERCC3, ERCC4, ERCC5), as they are frequently altered in various cancer types, and are part of the MSK-IMPACT panel25. This evidence concerns the gene ERCC2 and cancer.